|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Control of Toll-like Receptor 7 Expression Is Essential to Restrict Autoimmunity and Dendritic Cell Proferation显示文摘 | Jonathan AD Prapaporn P Rebecca S | 2007 | Immunl2007，27，： | 1 |
| 2 | Plasma vitellogenin of grouper ( Epinephelus malabaricus ): Isolation and properties显示文摘 | Prapaporn Utarabhand Paiboon Bunlipatanon | 1996 | Comparative Biochemistry and Physiology Part C: Comparative Pharmacology and Toxicology1996，，2： | 1 |
| 3 | Kindergarten’s Scientific Concepts and Skills in the Tree Unit显示文摘 | Mantana Kongpa Prapaporn Jantaburom Denis Byne Nujalin Obmasuy Chokchai Yuenyong | 2014 | Procedia - Social and Behavioral Sciences2014，，： | 1 |
| 4 | Purification and characterization of a lectin from the banana shrimp Fenneropenaeus merguiensis hemolymph显示文摘 | Wanida Rittidach Nisa Paijit Prapaporn Utarabhand | 2006 | BBA - General Subjects2006，，1： | 1 |
| 5 | Disruption of testicular steroidogenesis and epididymal func- tion by inhaled benzo(a)pyrene显示文摘 | Inyang Frank Ramesh Aramandla Kopsombut Prapaporn | 2003 | Reproductive Toxicology2003，17，5： | 1 |
| 6 | Characterization of microemul- sion structures in the pseudoteruary phase diagram of isopropyl palmitate/water/Brij 97: 1-butanol显示文摘 | Prapaporn B Karen K Anja G | 2006 | AAPS Pharm-SciTech2006，7，2： | 1 |
| 7 | Influence of oil con- tent on physicochemical properties and skin distribution of Nile red -loaded NLC显示文摘 | Veerawat T Prapaporn B Eliana B S | 2008 | J Control Release2008，128，： | 1 |
| 8 | Nanoencapsulation of polyphenols for protective effect against colon–rectal cancer显示文摘 | Isis S. Santos Bruno M. Ponte Prapaporn Boonme Amélia M. Silva Eliana B. Souto | 2013 | Biotechnology Advances2013，，5： | 1 |
| 9 | Oncology and reproductive outcomes over 16 years of malignant ovarian germ cell tumors treated by fertility sparing surgery显示文摘BACKGROUND Malignant ovarian germ cell tumors(MOGCT)are rare and frequently occur in women of young and reproductive age and the oncologic and reproductive outcomes after fertility-sparing surgery(FSS)for this disease are still limited.AIM To evaluate the oncology and reproductive outcomes of MOGCT patients who underwent FSS.METHODS All MOGCT patients who underwent FSS defined as the operation with a preserved uterus and at least one side of the ovary at our institute between January 2005 and December 2020 were retrospectively reviewed.RESULTS Sixty-two patients were recruited for this study.The median age was 22 years old and over 77%were nulliparous.The three most common histology findings were immature teratoma(32.2%),dysgerminoma(24.2%),and yolk sac tumor(24.2%).The distribution of stage was as follows;Stage I,74.8%;stage II,9.7%;stage III,11.3%;and stage IV,4.8%.Forty-three(67.7%)patients received adjuvant chemotherapy.With a median follow-up time of 96.3 mo,the 10-year progressionfree survival and overall survival were 82.4%and 91%,respectively.For reproductive outcomes,of 43 patients who received adjuvant chemotherapy,18(41.9%)had normal menstruation,and 17(39.5%)resumed menstruation with a median time of 4 mo.Of about 14 patients who desired to conceive,four were pregnant and delivered good outcomes.Only one case was aborted.Therefore,the successful pregnancy rate was 28.6%CONCLUSION The oncology and reproductive outcomes of MOGCT treated by FSS are excellent.Many patients show a long survival time with normal menstruation.However,the obstetric outcome is not quite satisfactory. | Muangloei Rungoutok Prapaporn Suprasert | 2022 | World Journal of Clinical Oncology2022，13，10： | 0 |
| 10 | Microemulsion-based hydrogels of itraconazole:Evaluation of characteristics and stability显示文摘Itraconazole (ITZ) is a broad spectrum triazole antifungal drug and commercially available as oral forms. However, effective topical forms are interesting to avoid systemic adverse effects,to directly deliver antifungal drugs to the target sites and to enhance patient compliance (1)Microemulsion-based hydrogel (MBH), a semisolid form of microemulsion (ME), is one of novel formulations practically used as topical drug carriers [2]. | Prapaporn Boonme Jarika Kaewbanjong Sugitta Sangduangyang Suttipa Suksawat Veerawat Teeranachaideekul | 2016 | Asian Journal of Pharmaceutical Sciences2016，11，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员